To evaluate the role of PRLR signaling during leukemogenesis, paired diagnosis-relapse AML samples were analyzed for their PRLR and Stat5 mRNA levels to track the expression of the receptor and the main secondary messenger through the course of the disease. This evidence concerns the gene STAT5A and acute myeloid leukemia.